February 04, 2020
Study Identifies Interaction Site for Serotonin Type 3A and RIC-3 Chaperone
To address the receptor dysfunction associated with several serious neurological diseases, Michaela Jansen, Pharm.D., Ph.D., from the Texas Tech University Health Sciences Center School of Medicine recently completed a study that provides novel insights into a protein-protein interaction that may one day lead to more effective treatments for these disorders. The study, “Delineating the site of interaction of the 5-HT3A receptor with the chaperone protein RIC-3,” was recently published in Biophysical Journal.
